EMA

The European Medicines Agency (EMA) is a decentralised agency of the European Union, located in London. The Agency is responsible for the scientific evaluation of medicines developed by pharmaceutical companies for use in the European Union. It began operating in 1995.

www.ema.europa.eu

EMA RSS Channel

Filters
List of articles in category EMA
Title Published Date
ECDC and EMA highlight considerations for additional and booster doses of COVID-19 vaccines 06 September 2021
AstraZeneca's COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets 07 April 2021
Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna 29 March 2021
EMA's safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events 15 March 2021
EMA recommends COVID-19 Vaccine Janssen for authorisation in the EU 11 March 2021
EMA starts rolling review of the Sputnik V COVID-19 vaccine 08 March 2021
EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca 12 January 2021
Update on assessment of the BioNTech and Pfizer BNT162b2 vaccine marketing authorisation application 15 December 2020
EMA receives application for conditional marketing authorisation of COVID-19 mRNA vaccine BNT162b2 01 December 2020
EMA receives application for conditional marketing authorisation of Moderna COVID-19 vaccine 01 December 2020
EMA endorses use of dexamethasone in COVID-19 patients on oxygen or mechanical ventilation 30 September 2020
Global regulators commit to cooperate on observational research in the context of COVID-19 21 May 2020
First vaccine to protect against Ebola 28 October 2019
EMA/FDA analysis shows high degree of alignment in marketing application decisions between EU and US 29 August 2019
EMA to relocate to Amsterdam, the Netherlands 22 November 2017
Green light given for new EudraVigilance system for collection and monitoring of suspected adverse reactions 29 May 2017
Launch of PRIME - Paving the way for promising medicines for patients 10 March 2016
Human medicines: highlights of 2015 22 January 2016
EMA's medical literature monitoring enters into full operation 09 September 2015
EMA and US FDA release first conclusions of parallel assessment of quality-by-design applications 21 August 2013

Business & Industry

Research & Development

Conferences & Events

Regulatory Affairs